Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs LSD

Microdoses of LSD enhance neural complexity, study finds

by Eric W. Dolan
April 1, 2024
in LSD, Microdosing
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A recent study has shown that even very low doses of LSD can enhance the complexity of brain activity, a finding that might have significant implications for our understanding of consciousness and possibly for therapeutic applications.

The study, published in the journal Neuropsychopharmacology, found that while substances like THC (tetrahydrocannabinol) and methamphetamine did not produce the same effect, LSD distinctly increased neural complexity and affected brain wave patterns associated with states of consciousness.

Neural complexity is a concept that attempts to quantify the intricate patterns of activity within the brain. This measure reflects the “richness” of one’s mental experience, which can vary dramatically from one state of consciousness to another. High levels of neural complexity are associated with a richer, more varied experience of consciousness, whereas lower levels are associated with reduced consciousness, such as in sleep or under the influence of certain sedatives.

The focus on neural complexity in this study stems from a theory known as the “entropic brain hypothesis,” which proposes that the therapeutic benefits of psychedelics are partly due to their ability to increase the brain’s level of entropy, thereby disrupting rigid, maladaptive patterns of thought and behavior.

The new study analyzed data from three separate drug trials conducted at the Human Behavioral Pharmacology Laboratory at the University of Chicago, that compared psychoactive substances (LSD, THC, and methamphetamine) against placebo conditions. A total of 73 healthy adults participated in these trials.

“I want to know how humans gain deeper insight and observation into themselves, life, and being during altered states of consciousness,” said study author Conor H. Murray, an assistant project scientist at UCLA and the founder of Psynautics.com. “Since I’m particularly interested in the neurobiological basis of consciousness and altered states, I decided to analyze all three studies to determine whether a neural correlate of consciousness was affected by the LSD microdoses vs, the THC doses vs, the meth doses.”

For LSD, doses of 13 or 26 micrograms (µg) were used. These amounts are substantially lower than the doses typically associated with a full psychedelic experience, which often exceeds 100 µg.

THC, the psychoactive component in cannabis, was administered in doses of 7.5 mg and 15 mg. These doses were intended to reflect the range of THC that might be consumed in a more controlled setting, producing subjective intoxication and performance impairments without reaching the higher levels often seen in recreational cannabis use.

Methamphetamine was administered in doses of 10 mg and 20 mg. These doses are based on prior studies that have identified them as effective in producing noticeable subjective, behavioral, and neural effects in healthy volunteers.

During each session, participants’ brain activity was recorded using electroencephalography (EEG), specifically focusing on neural complexity through the Limpel-Ziv complexity measure. This method quantifies the diversity of signal patterns in the EEG data, offering insights into the brain’s operational complexity. In addition to EEG recordings, participants provided self-reports on their mood states and perceived drug effects at various points throughout the session.

LSD emerged as the only substance among the three that dose-dependently increased neural complexity, suggesting a unique impact on brain function that may underpin its consciousness-expanding effects. This increase in neural complexity was also accompanied by reductions in delta and theta power, which are brain wave frequencies typically associated with deeper, less conscious states such as sleep.

These reductions in delta and theta power correlated with self-reported feelings of elation among participants, suggesting a link between the altered brain activity induced by LSD and the subjective experience of elevated mood or happiness.

The changes in brain activity were particularly intriguing because they were observed even at very low doses of LSD, well below those that induce the full psychedelic experience.

The findings provide evidence “that even very low doses of LSD might ‘expand consciousness’ as defined by a hotly debated theory of consciousness; but we still don’t know whether this is a good thing or not — we haven’t found out yet how this brain change might actually affect brain or mental health or cognitive function,” Murray told PsyPost.

Interestingly, while THC and methamphetamine also modulated brain activity, their effects did not mirror those of LSD. THC-induced reductions in alpha power were associated with altered states of consciousness, but the drug did not increase neural complexity in the way LSD did. Methamphetamine, on the other hand, showed stimulant-like responses without significant changes in neural complexity or consciousness states.

“I was surprised that neural complexity did not increase after THC, which induced psychedelic-like altered states; but did increase after the microdoses of LSD, which did not induce psychedelic-like altered states,” Murray said. “The field to this point had believed that neural complexity is the reason how psychedelic-like altered states happen. This surprising finding showed that this was not the case, that neural complexity was neither necessary nor sufficient for psychedelic-like altered states.”

The new research has some limitations to consider, including the pooling of data from three separate studies and the absence of measures for “richness of experience,” a factor previously associated with neural complexity. These limitations highlight the need for further research to deepen our understanding of how low doses of LSD and other psychedelics affect the brain and consciousness.

“The major caveat was that we didn’t ask participants about subtle changes in consciousness, like whether their sense of smell was enhanced, or whether they noticed intricacies after the microdoses of LSD that they didn’t notice on placebo,” Murray noted. “It’s possible that the increased entropy would be related to these subtle changes.”

“But since we only asked about large altered states effects, and stimulant effects, etc., none of that showed any association to the increased entropy, which begs the question as to whether entropy can increase even when consciousness is not altered at all – of course, the caveat again being that we did not have every subtle shade of minor alterations to ask about.”

The findings open up new avenues for exploring the therapeutic potential of psychedelics, particularly in microdosing practices. Future studies are needed to assess the long-term effects of these practices on mental health and well-being, as well as to explore the mechanisms behind the observed increase in neural complexity and its implications for consciousness and cognition.

“The immediate next step is to determine whether the increased neural complexity explains the improved behavioral responses we found in a facial recognition task after the low doses of LSD in the same study,” Murray told PsyPost. “Or maybe the increased complexity actually hindered those responses, we don’t know.”

“The real long-term goals are to understand what brain changes are occurring when people have meaningful insights and observations, so we can try to target these more specifically to refine and improve our ability to have meaningful therapeutic effects and scientific observations with high signal to noise ratio.”

The study, “Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine,” was authored by Conor H. Murray, Joel Frohlich, Connor J. Haggarty, Ilaria Tare, Royce Lee, and Harriet de Wit.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails
Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025

Researchers investigating the psychedelic drug DOPR discovered that very low doses can enhance motivation in low-performing mice—without triggering behaviors linked to hallucinations. The findings point to the therapeutic potential of psychedelics at doses too low to alter perception.

Read moreDetails
Is childhood trauma linked to challenging ayahuasca experiences? New study has surprising answer
LSD

New study shows LSD changes brain connectivity in unique ways compared to MDMA and amphetamines

March 27, 2025

A new brain imaging study finds LSD alters brain connectivity in unique ways, setting it apart from MDMA and amphetamine despite some shared effects.

Read moreDetails
Study finds microdosing LSD is not effective in reducing ADHD symptoms
ADHD

Study finds microdosing LSD is not effective in reducing ADHD symptoms

March 23, 2025

Microdosing LSD has no clear benefit for ADHD, according to a new placebo-controlled clinical trial published in JAMA Psychiatry.

Read moreDetails
LSD reshapes the brain’s response to pain, neuroimaging study finds
LSD

Psychedelics use is linked to lower odds of frequent bad headaches

March 19, 2025

A study of British adults found that those who had used psychedelics were 25% less likely to report frequent bad headaches, adding to growing research on psychedelics’ potential medical benefits.

Read moreDetails
Relaxation — not mystical experiences — emerges as best predictor of psychedelic therapy’s impact in surprising new study
LSD

Relaxation — not mystical experiences — emerges as best predictor of psychedelic therapy’s impact in surprising new study

November 8, 2024

Recent research found that psychedelic-assisted therapy reduced depressive symptoms, with relaxation during sessions being the strongest predictor of improvement.

Read moreDetails
New research reveals distinct cognitive effects of psychedelics and MDMA
LSD

New research reveals distinct cognitive effects of psychedelics and MDMA

August 22, 2024

Psychedelics impair attention and decision-making during use but may boost creativity afterward. In contrast, MDMA primarily disrupts memory, with no lasting cognitive benefits—highlighting the complex, varied effects of these substances on the brain.

Read moreDetails
LSD reshapes the brain’s response to pain, neuroimaging study finds
LSD

LSD reshapes the brain’s response to pain, neuroimaging study finds

August 20, 2024

LSD alters brain activity and connectivity in key regions associated with pain processing, offering potential insights for pain management and the therapeutic use of psychedelics.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Could creatine slow cognitive decline? Mouse study reveals promising effects on brain aging

ChatGPT and “cognitive debt”: New study suggests AI might be hurting your brain’s ability to think

Frequent dreams and nightmares surged worldwide during the COVID-19 pandemic

Vagus nerve signals influence food intake more in higher socio-economic groups

People who think “everyone agrees with me” are more likely to support populism

What is the most attractive body fat percentage for men? New research offers an answer

Longer antidepressant use linked to more severe, long-lasting withdrawal symptoms, study finds

New psychology study sheds light on mysterious “feelings of presence” during isolation

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy